ArticleCancer & metabolism2025

Interplay between malic enzyme 2, de novo serine synthesis, and the malate-aspartate shuttle drives metabolic adaptation in triple-negative breast cancer.

Jin Heon Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.